Drive adoption of QUELIMMUNE for ultra-rare pediatric AKI, expanding revenue and doubling the customer baseAdvance SeaStar Medical’s ...
Alongside the release of abstracts related to the American Society of Hematology meeting next month in San Diego, and as part of the firm’s third-quarter update, Beam Therapeutics Inc. disclosed that ...
Beam Therapeutics Inc. disclosed that one patient died in the phase I/II trial testing BEAM-101 in sickle cell disease (SCD), though the case of respiratory failure was determined by the investigator ...
Policy Interpretation Ruling Titles II and XVI: Evaluating Cases Involving Sickle Cell Disease (SCD) Purpose: This Social Security Ruling (SSR) provides background information on SCD and how we ...
User-Created Clip February 18, 2020 2020-02-18T09:28:47-05:00https://images.c-span.org/Files/8a4/20200218093027002_hd.jpgAdm. Giroir on SCD Part II Adm. Giroir on SCD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback